Erste Asset Management Gmb H Voyager Therapeutics, Inc. Transaction History

Erste Asset Management Gmb H

$11.9 Trillion
Q2 2025

A detailed history of Erste Asset Management Gmb H transactions in Voyager Therapeutics, Inc. stock. As of the latest transaction made, Erste Asset Management Gmb H holds 1,116,793 shares of VYGR stock, worth $6.02 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,116,793

Previous 1,116,793 -0.0%

Holding current value

$6.02 Million

Previous $3.83 Billion 9.96%

% of portfolio

0.03%

Previous 0.05%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	BUY	$3.38 - $6.04 $197,442 - $352,826	58,415 Added 5.52%	1,116,793 $3.83 Billion
Q3 2024 Nov 14, 2024	BUY	$5.77 - $9.27 $6.11 Million - $9.81 Million	1,058,378 New	1,058,378 $6.19 Billion
Q3 2023 Nov 26, 2024	SELL	$7.55 - $11.25 $604,000 - $900,000	-80,000 Reduced 7.03%	1,058,378 $8.2 Billion
Q2 2023 Nov 26, 2024	SELL	$6.94 - $13.99 $208,200 - $419,700	-30,000 Reduced 2.76%	1,058,378 $12.1 Billion
Q1 2023 Nov 26, 2024	SELL	$6.0 - $10.78 $300,000 - $539,000	-50,000 Reduced 4.39%	1,088,378 $8.39 Billion
Q3 2022 Nov 26, 2024	BUY	$5.57 - $7.47 $445,600 - $597,600	80,000 Added 7.56%	1,138,378 $6.76 Billion
Q2 2022 Nov 26, 2024	BUY	$4.82 - $10.09 $5.2 Million - $10.9 Million	1,079,478 Added 1832.73%	1,138,378 $6.73 Billion
Q1 2022 Nov 22, 2024	BUY	$2.75 - $9.44 $715,000 - $2.45 Million	260,000 Added 27.0%	1,222,900 $9.36 Billion
Q4 2021 Nov 22, 2024	BUY	$2.47 - $5.55 $505,169 - $1.14 Million	204,522 Added 19.32%	1,262,900 $3.59 Billion
Q3 2021 Nov 22, 2024	BUY	$2.63 - $4.12 $578,600 - $906,400	220,000 Added 29.61%	962,900 $2.55 Billion
Q2 2021 Nov 22, 2024	BUY	$3.94 - $5.44 $591,000 - $816,000	150,000 Added 25.3%	742,900 $3.07 Billion
Q1 2021 Nov 22, 2024	BUY	$4.61 - $9.04 $945,050 - $1.85 Million	205,000 Added 52.85%	592,900 $2.81 Billion
Q4 2020 Nov 22, 2024	BUY	$7.15 - $12.28 $321,750 - $552,600	45,000 Added 13.12%	387,900 $2.82 Billion
Q3 2020 Nov 22, 2024	SELL	$10.01 - $13.75 $7.16 Million - $9.84 Million	-715,478 Reduced 67.6%	342,900 $3.68 Billion
Q2 2020 Nov 22, 2024	BUY	$8.05 - $14.21 $72,450 - $127,890	9,000 Added 2.7%	342,900 $4.3 Billion
Q1 2020 Nov 22, 2024	BUY	$6.8 - $14.66 $88,400 - $190,580	13,000 Added 4.05%	333,900 $3.03 Billion
Q4 2019 Nov 22, 2024	SELL	$12.82 - $16.85 $9.45 Million - $12.4 Million	-737,478 Reduced 69.68%	320,900 $4.33 Billion
Q3 2019 Nov 22, 2024	BUY	$16.31 - $28.29 $114,169 - $198,030	7,000 Added 2.34%	305,900 $5.26 Billion
Q1 2019 Nov 22, 2024	SELL	$8.0 - $19.66 $6.08 Million - $14.9 Million	-759,478 Reduced 71.76%	298,900 $5.71 Billion
Q4 2018 Nov 26, 2024	SELL	$8.59 - $18.05 $8.59 Million - $18 Million	-999,478 Reduced 94.43%	58,900 $529 Million

Others Institutions Holding VYGR

# of Institutions

119

Shares Held

32.8M

Call Options Held

32.9K

Put Options Held

22.7K

View Full List

About Voyager Therapeutics, Inc.

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $208M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

More about VYGR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Account

Erste Asset Management Gmb H Voyager Therapeutics, Inc. Transaction History